112 related articles for article (PubMed ID: 2107018)
1. Cerebrospinal fluid pressure and prolactin in empty sella syndrome.
Maira G; Anile C; De Marinis L; Mancini A; Barbarino A
Can J Neurol Sci; 1990 Feb; 17(1):92-4. PubMed ID: 2107018
[TBL] [Abstract][Full Text] [Related]
2. Relationships between intracranial pressure and diurnal prolactin secretion in primary empty sella.
Maira G; Anile C; Cioni B; Menini E; Mancini A; De Marinis L; Barbarino A
Neuroendocrinology; 1984 Feb; 38(2):102-7. PubMed ID: 6425707
[TBL] [Abstract][Full Text] [Related]
3. Prolactin dynamics in normoprolactinemic primary empty sella: correlation with intracranial pressure.
Barbarino A; De Marinis L; Mancini A; D'Amico C; Sambo P; Passeri M; Anile C; Maira G
Horm Res; 1987; 27(3):141-51. PubMed ID: 3121488
[TBL] [Abstract][Full Text] [Related]
4. TSH and prolactin responses to thyrotropin releasing hormone (TRH) and domperidone in patients with empty sella syndrome.
Valensi P; Combes ME; Perret G; Attali JR
J Endocrinol Invest; 1996 May; 19(5):293-7. PubMed ID: 8796337
[TBL] [Abstract][Full Text] [Related]
5. Subnormal prolactin responsiveness to thyrotropin-releasing hormone (TRH) in women with primary empty sella syndrome.
Celani MF; Giambuzzi G; Simoni M; Montanini V
J Endocrinol Invest; 1987 Aug; 10(4):421-5. PubMed ID: 3119699
[TBL] [Abstract][Full Text] [Related]
6. Prolactin secretion in the empty sella syndrome, in prolactinomas and in acromegaly.
Brismar K
Acta Med Scand; 1981; 209(5):397-405. PubMed ID: 6787839
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of serum prolactin response to sequential thyrotropin-releasing hormone and chlorpromazine stimulation in patients with primary empty sella syndrome.
Futterweit W; Smith H; Holt JE
Fertil Steril; 1984 Oct; 42(4):573-8. PubMed ID: 6436062
[TBL] [Abstract][Full Text] [Related]
8. Blood-cerebrospinal fluid barrier for prolactin in empty sella syndrome.
Coculescu M; Temeli E; Oprescu M; Simionescu N
Endocrinologie; 1981; 19(3):199-206. PubMed ID: 7291947
[TBL] [Abstract][Full Text] [Related]
9. Twenty-four-hour prolactin secretory patterns in women with galactorrhea, normal menses, normal random prolacting levels and abnormal sellar tomograms.
Kapcala LP; Molitch ME; Arno J; King LW; Reichlin S; Wolpert SM
J Endocrinol Invest; 1984 Oct; 7(5):455-60. PubMed ID: 6439770
[TBL] [Abstract][Full Text] [Related]
10. [Determination of pituitary hormones in cerebrospinal fluid in normal subjects and in hypothalamo-pituitary diseases. Secreting or non-secreting pituitary adenoma, empty sella syndrome, hypothalamic syndromes].
Turpin G; Heshmati HM; Roger M; Cesselin F; Lagoguey M; Baulieu JL; De Gennes JL
Ann Endocrinol (Paris); 1980; 41(1):21-30. PubMed ID: 7396391
[TBL] [Abstract][Full Text] [Related]
11. Enhanced prolactin responsiveness to galanin in patients with Cushing's disease.
Invitti C; Pecori Giraldi F; Tagliaferri A; Scacchi M; Dubini A; Cavagnini F
Clin Endocrinol (Oxf); 1993 Aug; 39(2):213-6. PubMed ID: 7690312
[TBL] [Abstract][Full Text] [Related]
12. Prolactin dynamics in patients with non-secretin tumours of the hypothalamic-pituitary region.
Barbarino A; De Marinis L; Mancini A; Menini E; D'Amico C; Passeri M; Sambo P; Anile C; Maira G
Acta Endocrinol (Copenh); 1985 Sep; 110(1):10-6. PubMed ID: 3929517
[TBL] [Abstract][Full Text] [Related]
13. Opioid-dopaminergic interactions in primary empty sella.
Mancini A; Conte G; Fiumara C; Fabrizi ML; Iacona T; Zuppi P; Colosimo C; De Marinis L
Exp Clin Endocrinol; 1993; 101(5):277-82. PubMed ID: 8299703
[TBL] [Abstract][Full Text] [Related]
14. Decreased prolactin responsiveness to thyrotrophin-releasing hormone and metoclopramide in hyperthyroidism.
Röjdmark S; Carlsson A
Acta Endocrinol (Copenh); 1985 Oct; 110(2):221-6. PubMed ID: 2998132
[TBL] [Abstract][Full Text] [Related]
15. Dynamic evaluation of prolactin secretion by successive TRH and metoclopramide stimulations.
Kauppila A; Heikkinen J; Viinikka L
Acta Endocrinol (Copenh); 1986 Jan; 111(1):10-6. PubMed ID: 3080846
[TBL] [Abstract][Full Text] [Related]
16. Chronobiological study of pituitary adenomas and of the empty sella syndrome.
Ferrari E; Bossolo PA; Baldi F; Daguati M; Fioravanti M; Facara S
Chronobiologia; 1982; 9(2):241-8. PubMed ID: 7117046
[TBL] [Abstract][Full Text] [Related]
17. The interrelationships between prolactin and thyrotrophin secretion following dopaminergic blockage in patients with mild hyperprolactinaemia without any demonstrable pituitary tumour.
Spitz IM; Haas M; Trestian S; Zylber-Haran E; Shilo S
Clin Endocrinol (Oxf); 1983 Sep; 19(3):285-94. PubMed ID: 6414745
[TBL] [Abstract][Full Text] [Related]
18. The prolactin-releasing mechanism of the hypothalamo-pituitary axis in pregnancy.
Kubota T; Yaoi Y; Nagae M; Kumasaka T; Saito M
Fertil Steril; 1984 Nov; 42(5):724-9. PubMed ID: 6436068
[TBL] [Abstract][Full Text] [Related]
19. Semicircadian rhythm of dopamine release in the mediobasal hypothalamus in awake rats during pseudopregnancy: evidence that a thyrotropin-releasing hormone analogue stimulates dopamine release and thereby inhibits prolactin secretion.
Timmerman W; Poelman RT; Westerink BH; Schuiling GA
Neuroendocrinology; 1995 Nov; 62(5):434-43. PubMed ID: 8559275
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.
De Marinis L; Mancini A; Minnielli S; Masala R; Anile C; Maira G; Barbarino A
Metabolism; 1985 Oct; 34(10):917-22. PubMed ID: 4046835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
